Influence of ABCB1 polymorphisms upon the effectiveness of standard treatment for acute myeloid leukemia: A systematic review and meta-analysis of observational studies

MDR1 mRNA expression and MDR1 gene variants as predictors of response to chemotherapy in patients with acute myeloid leukaemia: a meta-analysis

(2013) Chrysoula Doxani et al.   BIOMARKERS

Association between theMDR1gene variant C3435T and risk of leukaemia: a meta-analysis

(2013) B-B. Zhang et al.   EUROPEAN JOURNAL OF CANCER CARE

Association of MDR1 G2677T polymorphism and leukemia risk: evidence from a meta-analysis

(2013) Yulan Yan et al.   TUMOR BIOLOGY

ABCB1 genetic variation and P-glycoprotein expression/activity in a cohort of Brazilian acute myeloid leukemia patients

(2012) Marcos Antonio Mauricio Scheiner et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

MDR1 C3435T polymorphism and cancer risk: a meta-analysis based on 39 case–control studies

(2012) Xiaojing Sheng et al.   MOLECULAR BIOLOGY REPORTS

Idarubicin is superior to daunorubicin in remission induction ofde novoacute myeloid leukemia patients with highMDR1expression

(2012) Pengcheng Shi et al.   PHARMACOGENOMICS

Activation of STAT5 confers imatinib resistance on leukemic cells through the transcription of TERT and MDR1

(2011) Osamu Yamada et al.   CELLULAR SIGNALLING

Association of ABCB1 polymorphisms with survival and in vitro cytotoxicty in de novo acute myeloid leukemia with normal karyotype

(2010) H Gréen et al.   PHARMACOGENOMICS JOURNAL

C3435T polymorphism of the MDR1 gene is not associated with P-glycoprotein function of leukemic blasts and clinical outcome in patients with acute myeloid leukemia

(2008) Eun-Hye Hur et al.   LEUKEMIA RESEARCH

Acute Myeloid Leukemia: The Challenge of Capturing Disease Variety

(2008) B. Lowenberg   Hematology-American Society of Hematology Education Program